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SUMMARY
Platelet concentrates were shown to contain 18-38 mg/100 ml
of a plithalate plasticizer (Dr-11P) which arose by migration from
the vinyl plastic packs in which the platelets were prepared and
stored. Transfusion of these platelets into 6 adult patients
win leukemia resulted in peak blood plasma levels of DI:HP
ran«ing from 0.34 - 0.83 mg/100 ml (anproxinately 0.02 mg/100 r► 1
plasma per mg DEHP administered per square mater of sur.f.^ce area).
The blood levels fell mono-ex ponentiall y with a mean rite of 2.83
percent per minute and a half-life of 28.0 minutes. Urine was
assayed by a method that 1;,ould measure unchanged DE11P as well
as all phthalic acid-containing metabolites. In two patients,
at most 60 and 90. of the infused dose, respectively, was
excreted in the urine collected for 24 hours post-transfusion.
These estimates, however, could be high due to the simultaneous
excretion of DEHP 2`maining from previous transfusions or arising
from uncontrollec: environmental exposures.
1
I .
Di(2-ethylhc-xyl)phth,ilate (DE11P) is widely used fls a
plasticizer in the formulation of vinyl plastics. It serves to
make the polymeric plastic pliable; in this role its concontra-
tion may r-.ach 30-407 of the total weight of the finished
product. In 1972 Jaego-- and Ruhin l reported the migration of
this plasticizer from vinyl plastic nags into human blood
stored for transfusion. The rate of migration was found to be
0.25mg/100ml blood/24 hours of storage at 4°C. Marcel and
Noel 2 , 3 have reported similar obsorvations . In 1973 Jaer,e!r
and Rubin' also reported on the migrati; n of llL'IIP into platelet-
rich plasma stored in vtnv'_ plastic bags. The rate of plasticizer
migration was found to be approximately 20mg/100m.1 plasma/24 hours
of storage at room temperature. These results have recently
been confirmed by Valeri, et a15.
DEHP has been found in a variety of tissues obtained at
autopsy from humans who had received transfusions of blood stored
in vinyl plastic bags 1 . The plasticizer has also been identi.ied
in tissues of humans who have not received transfusions of blood
nor had any direct contact of their own blood with a medical
plastic device E . Presumably, these latter observations are due
to envirr.nr ^ntal contamination 7 , although endogenous synthesis
of DE11P in trace amounts, in mamrr:alian tissues has not been entirely
i
rul,.d cut.
'	 I	 I	 I	 I	 i	 I
2.
Schulz and Rubin 8 havr reported that in rats intravenously
administered D1,11P (emulsified i.l a solution of bovine serum
albumin) disappears from the circulation at a bi-exponential
rate, the initial phase having a half-life of 4.5-9 ninutes and
the latter phase having a half-liTe of 22	 minutes. The
.,nitial rapid phase was shown to be due to a rapid uptake into
the _-.iver. More recently 9 , DEIIP solubil.ized in a non-ionic
detergent (Tween 80) has been shown to disappear from rat blood
at a single exponential rate having a half.-Life of 21 minutes.
Under these conditions, accumulation in the liver does not occur.
These data emphasize the influence of trio rhvsical. state of DEEP
on its fate in vivo.
Patients with leukemia frequently receive transfusions of
platelet units that have been prepared and stored in vinyl plastic
bags and thus contain high levels of migrated DEIIP. This paper
reports on the blood levels and kinetics of disappearance of
DMIP in 6 such patients who received DEIIP during transfusion of
platelet-rich plasma that h-3 been stored for 24 hours at room
temperature in vinyl plastic ba gs. In addition the urinary
excretion of DEIIP ano? its metabolic derivatives have been
determined in two of these pat.Lents.
ME ;' ODS
Six adult thrombocytopenic males with acute nonlyrrrphocytic
leukemia who wore being treated at NCI Baltimore Cancer Research
Center were studied. All of the patients had received prior
3.
transfusions with packed red blood cells and platelet concentrates.
1 1he patients were in stable clin:^al condition and had normal
renal function as assessed by urinalysis	 and serum blood urea
nitrogen and creatinine. Two patients ( ? 2 and E 3) had mild
abnormalities of hepatic function, provably secondary to viral
hepatitis.
Platelet concentrates (PC) were prepared in acid-citrate-
dextrose (ACD) anticoagulant by 	 plateletpheresis technique.
Each unit of PC was stored in a final volume of 20-30ml in plastic
bags (F'enwal PA220 transfer Lack) for 22-26 hours at room
temperature (approximately 24°C) with continuous ge-itle agitation.
Six to eight units of PC were pooled just prior _o administration.
An aliquot of the pooled concentrate was centrifuged z,t 4000xg
for ten minutes in glass test tubes and tho platelet-poor plasma
was separated and used for the measurement of 	 I
The platelets %•.,er.e infused over a twenty to
thirty minute period exce p t in one patient ( '4 5) who received a
one-hour transfusion. A 6-7ml venous blood sample was obtained
from the opposite arm prior to transfusion, immediately post-
transfusion and every 15 minutes thereafter for one hour. Sa.mp1es
were drawn using glass syringes and were transferred to glass test
tubes containing lml of ACD anticoagulant. These were kept in ice
prier to separation of plasma for measurement of DEPP. Plasma
1
J i
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samples were maintained in the frozen state prior to assay. In
two patients, urine was collected for the 24 hours pro- transfusion
and for the 24 hours post-transfusion.
DE11P was assayed in plasma by the method of Piechockil0
involving the separation of the DE11P on a Celite 545 column.
DKIII) was measured by gas chromatographv on a 6 foot 3% SF-30
column using a flame ionization detector and hexacosane (C26) as
an internal standard. 1111 samples were corrected by subtracting
a blank value that was obtained by process:.ig an aliquot of
distilled water through the entire analyt.icil procedure. This
was done for each set of samples from each patient. The
individual blank values ranged from 0.0 3 -0.15 mg/100ml with a
mean of 0.07 mg/100ml. Plasma samples were further corrected
for dilution of the initial blood sample with ACD solution.
DFNIP and all phthalic acid-containing metabolic intermediates
of DMIP in urine were hydrolyzed to phthalic acid by the method
of Shaffer, et al l]. as previously described l	rollowing mcthylation
with diazomethane, the phthalic acid content was determined by
gas chromatographic analysis of the formed di.methvlphthalate on
a Gft. column of 3% SE-30 using flame ionization detection.
liexadecane (C16) was used as an internal standard for quantitaticn.
From the phthalic acid content of the hydrolyzed urine, the
f
j	 equivalent amount of DE11P could be calculates:. This latter amount
is presented as "DFI1P equivalents" and it represents the amount
5.
of DI:Hi' that appears in urine uncharged as well as that which
is excreted in the form of phthalic acid-containing rretaboli.te:z.
The amount of unchanged DhHP excreted into the urine was not
separately determined.
The disappearance rate of DE?iP from blood and the corresponding
half-life was determined for each patient following calculation
of the line of best fit of the data by a linear regression analysis.
V1,;sULTS
In Table 1 it can be seen that the preparation and storage
of platelets in vinyl. plastic bags resulted in levels of contamination
of DEHP ranging from 18-38 my/100ri1, thus confirming earlier
r
reports ''. The 'total amount of DEEP administered to patients
ranged froIil 2E-82 mg (o. 14-44 mg per square meter of surface
area). It can be seen from the Table that prior to the transfusion,
trace amounts of P1.IfP could be found in the plasma of 4 of the
6 patients. At the termination of the transfusion period, plasma
levels ranging from 0.34 - 0.83 rig/100 ml were observed. These
plasma levels correlated reasonably well with the dose of the
administered D111P in that the patient who received the lowest
dose per square meter of surface area (patient 01) had the lowest
blood level while the other patients receiving 2-2.5 times as
much of the plasticizer had blood levels approximately 2-2.5
times as high.
6.
In figure 1 are Shown the data for the disappearance of
DEIIP from the blood for each ,idividual pa' tent over a period
of 60 minutes following transfusion. It can be seen that the
blood levels fell in a mono-exponential fashion over this time
period. In Table 2 are shown the rate constants and half-lives
determined from the calculated line of best fit for each patient.
The mean disappearance rate was 2.83 + 0.45 percent per minute.
This correspcn(jed to a mean half-life of 28.0 -, 4.3 minutes.
In two of the patients, urine was collected prior to the
platelet transfusion period and for 24 hours after the transfusion.
T 	 -rine was assayed by a procedure (describcd in Methods)
that measured DE11P as well as all phthalic acid-containing
metabolites of DEHP including phthalic acid itself. The data,
shown in Table 3, are presented as eriuivalent amounts of DEIIP
recovered in the urine. It can be soon that prior to the trans-
fusion small amounts of DEIIP eguivz.lt2nt5 (9.0 and 13.8 mgs)
were excreted by the two patients. These amounts could possibly
have arisen from the urinary excretion of residual amounts of
DI7 111 1 received during prior transfusions. However, it should be
pointed out that there have been reports of phthalic acid-containing
molecules in the urine of a patient prior to open heart surgery
and blood transfusions ) and in the urine of normal controls12.
The sources of these compounds are not known but they could
arise from environmental exposures. In any event, the 3-6 fold
7.
increase in the amount of D1:111' equivalents excreted during the
24 hour period after transfusion indicate s excretion of a major
portion of the DE11P associated with the platelet transfusions
administered during this study. If the level of DE11I' excreted
during the pre-transfusion period is ignored, then the amounts
excreted during the 24 hours post-transfusior. can represent no
more than 60-90i of the administered DMIP. If it is assumed that
there is a continuous environmentally related level of excretion
of phthalic acid-containing molecules, comparable to that seen
during the Ire-transfusion period, then the net difference
between the pre-and post-transfusion periods would represent
the amount arising from the exooenously administered DE111". Thus,
a correspondingly smaller (but still significant) fraction of the
administered dose would be accounted for by excretion in the
urine during the first 24 hours.
DISCUSSION
These results confirm earlier reports of the contamination
of blood 1,2,3 or blood products 4,5 with a plasticizer, DE11P,
following storage in vinyl plastic bags. They, furthermore,
establish for the first time in humans the plasma levels that are
attained following transfusions of DEHP -contaminaz--^d products.
These levels average apprximately 0.02 mg/100 ml plasma for each
mg of DE11P administered per square meter of surface area.
The rate of disappearance of DUITP from plasma was mono-
8.
exponential and relatively rapid (rate constant - .0283 min-1).
Previous experiments in rats have shown that a suspension of DEHP,
emulsified in serum albumin, disappeared from plasma bi-exponentially8
while a detergent-.solubilized preparation disappeare% mono-expon-
entially with a rate constant quite comparable to that shown here
in human-	 Thus, based on kinetic behavior these results suggest
that the DLtiP that is administered to humans in vinyl plastic
stared-blood products e y4sts in a solubilized state rather than as
discrete,	 suspended oil droplets. The exact nature of the
physical state of DEHP following migration from a plastic surface
into blood plasma is not currently known although Needham and Luzzi l -)
have recently obse rvud droplets of oil in aqueous solut :.cns stored
in vinyl bags. Such information has important implications for the
ultimate disposition of DEHP in the human bony since previous
studies in the rat have shown different patterns of tissue
distribution for emulsified and detergent-solubili zed DEHP8'9.
It is of interest to note that the two patients with evidence
of mild abnormalities of hepatic function (f2 and #3) did not have
particularly unusual half-lives for DEHP disappearance. Although
patient #2 did have the longest half-life (^1.8 minutes) in
Table 2, patient 03 with a half-life of 21.5 minutes was below the
group mean and ranked only 3rO. in the series of six. Since
previous experiments in the rat 14 have indicated that the liver is
9.
the major site of metabolism of DEIII', these data suggest that
the liver abnormalities in these two patients were not sufficiently
severe to alter markedly their rate of DEUP disappearance from
blood.
The urinary data indicate that a major portion of the
administered DM11P is excreted within 24 hours although determination
of the exact quantitative portion is complicated by the pre-
transfusion excretion of si gnificant amounts of DEHP-related
material. F.xperintents with rats in which 14 C-radiolabelled D1,11P
was given intravenously have indicated rather extensive biliary
and fecal excretion of radioactivity. If the same mechanisms exist
in humans, then determination of D'MIP and/or its metabolites in
feces might allow for an even greater quantitative recovery of the
administered DMIP dose.
As indicated above, the assay procedure used for the urine
samples does riot distinguish between unchanged DE1IP and phthalic
acid-containing metabolites. Previous experiments with rats,$,15
however, have shown only trace quantities of unchanged D%FFP
in the urine with the major substances being water-soluble,
phthalic acid--containing metabolites whose structures have been
r
determined. ' Presumably there water-soluble metabolites comprise
the DEHP equivalents found in the urine of the human patients in
this study, but this has not been experimentally Bete mined.
10.
Autian 14 has recently reviewed the toxicology of the
phthalate plasticizers in animals and cell culture. However,
the extensive use of vinyl-stared blood and blood products
during the past decade has failed to reveal any definitive
adverse effects of such storage in human3. In addition, the
results presented here indicate a rapid clearance of DEtiP from
blood and extensive urinary excretion within 24 hours. However,
these facts should not diminish the concern for any possible
adv^-^
	
uiological effects of acute or chronic exposure to this
c ,)mpound, particularly when one considers the wid,- array of
debilitated states for which Mood or blood products are often
transfused. For example, Jacobson, et al l? have recently
reported altered hepatic morphology and function in rhe.,us
monkeys chronically transfused for a period of one year with
platelets prepared and stored in vinyl plastic bags. As long
as these type3 of biologics are to be stored in vinyl bags
and amounts of a foreign con,.pound that are reported here are
thus inadvertently administered to humans, the toxicologic
potential of such exposure must be exhaustively pursued. An
even better approach would be the development of alternate
plastic formulations that do not result in appreciable
migration of any chemical cone ti tucnts .
li
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DISAPPEAIL'1I1CF. RATES AND IIALF-LIVES FOR DEHP
Rate co:istant	 tl/2
Patient	 min-lx]02	 min
1	 3.32	 20.9
2	 1.66	 41.8
3.2.2	 21.5
4	 2.12	 32.7
5	 4.75	 14.6
6	 1.91	 36.4
Mean + S.E.	 2.83 + 0.45	 2a.0 + 4.3
iTATILr. 3 .
URINARY EXCRETION Or DE111'
1,
24 hr DE111' excretion
(in(j DIMP equivalents)
Total DE11P	 pre-trans:-	 host-trans-
Patient- 0 received (Piq)	 fusion	 fusion
3	 62.2	 9.0
max. 9,
excreted
90
4
	
67.8
	
13.8	 40.0
	
60
as 12 Hour collection immediately prior to transfusion: 1.250 ml
urine.
knot a complete 24 hotir collection but does contain all the urine
excreted during the first 8 hours and most of the urine excreted
during the subsequent 16 hours: 1650 ml urine.
.
Figure 1.	 Time-course for DF:li? disappearance from blood
plasma following platelet transfusions in humans.
Each figure, represents the data from a single patient:
and is identified with the respective patient number.
